The most well-known LNP cargo is mRNA, the key constituent of some of the early vaccines against COVID-19. But that is just one application ... is an LNP-based CRISPR-Cas9 candidate treatment ...

CRISPR-Cas9 genome editing exploits the CRISPR-Cas ... DNA templates for expression of gRNAs for different genome-editing applications in a cell-free one-pot reaction. Characterization of the ...

Distinct from the CRISPR-Cas9 system, the spokesperson added is that the development time of CRISPR-Cas3 assets can be advanced “in half the time and at a fraction of the cost of traditional ...

KAMPALA - Dr Matthias Magoola says the US Patent and Trademark Office (USPTO) has granted a patent for his invention of the first treatment of cancer using a novel composition of a guided Ribonucleic ...